Kobayashi Y, Ogino T, Hayashi T, Nonaka S, Harabuchi Y
Department of Otolaryngology, Asahikawa Medical College.
Nihon Jibiinkoka Gakkai Kaiho. 2000 Jun;103(6):761-9. doi: 10.3950/jibiinkoka.103.761.
Prognostic factors and treatment outcome of 74 patients with non-Hodgkin's lymphoma of Waldeyer's ring (male 34, female 16, median age 63 years) and cervical lymph nodes (male 17, female 7, median age 62 years) were analyzed retrospectively. The prognostic factors analyzed were: age, B-symptoms, serum LDH levels, and Ann Arbor stage. We also analysed the TNM classification (1987) of Waldeyer's ring lymphoma (previously referred as nasopharyngeal and oropharyngeal cancer) as a new prognostic factor. The 5-year-survival rate of the patients with Waldeyer's ring non-Hodgkin's lymphoma was 67%, compared with 34% for cervical lymph node lymphoma. In univariate analyses, unfavorable outcome was associated with age (age > 60 years), B-symptoms, elevated serum LDH level, and stage. Multivariate analysis showed that age and elevated serum LDH level were significant independent risk factors for death. The 5-year-survival rate according to TNM classification of Waldeyer's ring lymphoma was: T1 (4 cases) 75%, T2 (23 cases) 83%, T3 (10 cases) 56%, T4 (4 cases) 0%; according to N stage, N0 (15 cases) 91%, N1 (7 cases) 73%, N2 (11 cases) 55%, N3 (5 cases), M1 (3 cases) 0%, and according to TNM stage, stage I (one case) stage II (9 cases) 100%, stage III (12 cases) 80%, stage IV (19 cases) 34%. These results suggest that the N classification of Waldeyer's ring non-Hodgkin's lymphoma may be a new prognostic factor.
回顾性分析了74例韦氏环非霍奇金淋巴瘤患者(男性34例,女性16例,中位年龄63岁)及颈部淋巴结非霍奇金淋巴瘤患者(男性17例,女性7例,中位年龄62岁)的预后因素及治疗结果。分析的预后因素包括:年龄、B症状、血清乳酸脱氢酶(LDH)水平及Ann Arbor分期。我们还将韦氏环淋巴瘤(以前称为鼻咽癌和口咽癌)的TNM分类(1987年)作为一项新的预后因素进行了分析。韦氏环非霍奇金淋巴瘤患者的5年生存率为67%,而颈部淋巴结淋巴瘤患者为34%。单因素分析显示,不良预后与年龄(年龄>60岁)、B症状、血清LDH水平升高及分期有关。多因素分析表明,年龄和血清LDH水平升高是死亡的显著独立危险因素。根据韦氏环淋巴瘤的TNM分类,5年生存率为:T1(4例)75%,T2(23例)83%,T3(10例)56%,T4(4例)0%;根据N分期,N0(15例)91%,N1(7例)73%,N2(11例)55%,N3(5例),M1(3例)0%,根据TNM分期,I期(1例)II期(9例)100%,III期(12例)80%,IV期(19例)34%。这些结果提示,韦氏环非霍奇金淋巴瘤的N分类可能是一项新的预后因素。